COVID-19 datasets are public databases for sharing case data and medical information related to the COVID-19 pandemic.
Publisher | Date of first publication | In official use? | Update Frequency | Geographic Level | Timeseries | Testing Sites | Testing Number | Cases | Hospitalizations | Deaths | Vaccination Sites | Vaccination Number | Description |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Coders Against COVID/GISCorps [1] | March 22, 2020 [2] | Yes, by FEMA [3] and State of California [4] | Daily | Point (lat/long) | Yes | Yes | No | No | No | No | Yes | No | A dataset of COVID-19 testing locations in the United States and Puerto Rico |
USAFacts [5] | April 24, 2020 [6] | Yes, by CDC [7] | Daily | County | Yes | No | No | Yes | Yes | No | No | A dataset of county-level coronavirus cases and deaths that is updated daily | |
COVID Tracking Project [8] | March 7, 2020 [9] | No | Daily | State | Yes | No | Yes | Yes | Yes | Yes | No | No | A volunteer-run database of testing and medical stats in the United States |
Sentiment Analysis of users reviews on COVID-19 contact tracing mobile applications [10] [11] | March 2021 | This dataset is intended to support sentiment analysis of users' reviews on COVID-19 contact tracing mobile applications. |
Name | Geographic Level | Timeseries | Testing Sites | Testing Number | Cases | Hospitalizations | Deaths | Vaccination Sites | Vaccination Number |
---|---|---|---|---|---|---|---|---|---|
COVID-19 Diagnostic Laboratory Testing (PCR Testing) Time Series Archived 2021-03-12 at the Wayback Machine | State | Yes | No | Yes | No | No | No | No | No |
COVID-19 Reported Patient Impact and Hospital Capacity by Facility Archived 2021-03-12 at the Wayback Machine | Point (lat/long) | Yes | No | No | No | Yes | No | No | No |
COVID-19 Estimated Patient Impact and Hospital Capacity by State Archived 2021-03-12 at the Wayback Machine | State | No | No | No | No | Yes | No | No | No |
COVID-19 Reported Patient Impact and Hospital Capacity by State Archived 2021-03-08 at the Wayback Machine | State | No | No | No | No | Yes | No | No | No |
COVID-19 Reported Patient Impact and Hospital Capacity by State Timeseries Archived 2021-03-10 at the Wayback Machine | State | Yes | No | No | No | Yes | No | No | No |
GISAID, the Global Initiative on Sharing All Influenza Data, previously the Global Initiative on Sharing Avian Influenza Data, is a global science initiative established in 2008 to provide access to genomic data of influenza viruses. The database was expanded to include the coronavirus responsible for the COVID-19 pandemic, as well as other pathogens. The database has been described as "the world's largest repository of COVID-19 sequences". GISAID facilitates genomic epidemiology and real-time surveillance to monitor the emergence of new COVID-19 viral strains across the planet.
The global COVID-19 pandemic arrived in Europe with its first confirmed case in Bordeaux, France, on 24 January 2020, and subsequently spread widely across the continent. By 17 March 2020, every country in Europe had confirmed a case, and all have reported at least one death, with the exception of Vatican City.
The COVID-19 pandemic began in Asia in Wuhan, Hubei, China, and has spread widely through the continent. As of 1 November 2023, at least one case of COVID-19 had been reported in every country in Asia except Turkmenistan.
COVID-19 testing involves analyzing samples to assess the current or past presence of SARS-CoV-2. The two main types of tests detect either the presence of the virus or antibodies produced in response to infection. Molecular tests for viral presence through its molecular components are used to diagnose individual cases and to allow public health authorities to trace and contain outbreaks. Antibody tests instead show whether someone once had the disease. They are less useful for diagnosing current infections because antibodies may not develop for weeks after infection. It is used to assess disease prevalence, which aids the estimation of the infection fatality rate.
The first cases of the COVID-19 pandemic of coronavirus disease 2019 in North America were reported in the United States on 23 January 2020. Cases were reported in all North American countries after Saint Kitts and Nevis confirmed a case on 25 March, and in all North American territories after Bonaire confirmed a case on 16 April.
The COVID-19 pandemic was confirmed to have reached Oceania on 25 January 2020 with the first confirmed case reported in Melbourne, Australia. The virus has spread to all sovereign states and territories in the region. Australia and New Zealand were praised for their handling of the pandemic in comparison to other Western nations, with New Zealand and each state in Australia wiping out all community transmission of the virus several times even after re-introduction in the community.
The COVID-19 pandemic was confirmed to have reached South America on 26 February 2020 when Brazil confirmed a case in São Paulo. By 3 April, all countries and territories in South America had recorded at least one case.
The COVID-19 pandemic in Ethiopia was a part of the ongoing worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The virus was confirmed to have reached Ethiopia on 13 March 2020. The national government, led by Prime Minister Abiy Ahmed, declared a five-month state of emergency in April 2020 but has allowed economic activities to continue during the public health crisis.
The COVID-19 pandemic in Tuvalu is part of the ongoing worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The virus was confirmed to have reached Tuvalu on 20 May 2022. As of 31 August 2022, a total of 25,591 vaccine doses have been administered.
The COVID-19 pandemic in Anguilla is part of the ongoing global viral pandemic of coronavirus disease 2019 (COVID-19), which was confirmed to have reached the British Overseas Territory of Anguilla on 26 March 2020. On 26 April 2020, all patients had recovered and on 22 November a new imported case was announced.
The COVID Tracking Project was a collaborative volunteer-run effort to track the ongoing COVID-19 pandemic in the United States. It maintained a daily-updated dataset of state-level information related to the outbreak, including counts of the number of cases, tests, hospitalizations, and deaths, the racial and ethnic demographic breakdowns of cases and deaths, and cases and deaths in long-term care facilities.
NHS COVID-19 was a voluntary contact tracing app for monitoring the spread of the COVID-19 pandemic in England and Wales. It had been available since 24 September 2020 for Android and iOS smartphones, and can be used by anyone aged 16 or over.
The CDC publishes official numbers of COVID-19 cases in the United States. The CDC estimates that, between February 2020 and September 2021, only 1 in 1.3 COVID-19 deaths were attributed to COVID-19. The true COVID-19 death toll in the United States would therefore be higher than official reports, as modeled by a paper published in The Lancet Regional Health – Americas. One way to estimate COVID-19 deaths that includes unconfirmed cases is to use the excess mortality, which is the overall number of deaths that exceed what would normally be expected. From March 1, 2020, through the end of 2020, there were 522,368 excess deaths in the United States, or 22.9% more deaths than would have been expected in that time period.
There are many variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19). Some are believed, or have been stated, to be of particular importance due to their potential for increased transmissibility, increased virulence, or reduced effectiveness of vaccines against them. These variants contribute to the continuation of the COVID-19 pandemic.
Nextstrain is a collaboration between researchers in Seattle, United States and Basel, Switzerland which provides a collection of open-source tools for visualising the genetics behind the spread of viral outbreaks.
The term variant of concern (VOC) for SARS-CoV-2, which causes COVID-19, is a category used for variants of the virus where mutations in their spike protein receptor binding domain (RBD) substantially increase binding affinity in RBD-hACE2 complex, while also being linked to rapid spread in human populations.
Software for COVID-19 pandemic mitigation takes many forms. It includes mobile apps for contact tracing and notifications about infection risks, vaccine passports, software for enabling – or improving the effectiveness of – lockdowns and social distancing, Web software for the creation of related information services, and research and development software. A common issue is that few apps interoperate, reducing their effectiveness.
Theta variant, also known as lineage P.3, is one of the variants of SARS-CoV-2, the virus that causes COVID-19. The variant was first identified in the Philippines on February 18, 2021, when two mutations of concern were detected in Central Visayas. It was detected in Japan on March 12, 2021, when a traveler from the Philippines arrived at Narita International Airport in Tokyo.
Epsilon variant, also known as CAL.20C and referring to two PANGO lineages B.1.427 and B.1.429, is one of the variants of SARS-CoV-2, the virus that causes COVID-19. It was first detected in California, USA in July 2020.
{{cite journal}}
: Cite journal requires |journal=
(help)